| Rare mesenchymal breast entities that mimic malignancy: a single-institution experience of a challenging diagnosis CC Simoes, S Qiu, QD Nguyen, SS Hatch, J He Cureus 11 (2), 2019 | 10 | 2019 |
| Direct‐Acting Antiviral Treatment of Patients with Hepatitis C Resolves Serologic and Histopathologic Features of Autoimmune Hepatitis CC Simoes, OA Saldarriaga, NS Utay, AE Stueck, SK Merwat, SN Merwat, ... Hepatology Communications 3 (8), 1113-1123, 2019 | 9 | 2019 |
| Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers BM Nagalo, Y Zhou, EJ Loeuillard, C Dumbauld, O Barro, NM Elliott, ... Hepatology 77 (6), 1943-1957, 2023 | 6 | 2023 |
| Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy Y Zhang, M Gabere, MA Taylor, CC Simoes, C Dumbauld, O Barro, ... Frontiers in Oncology 12, 1042250, 2022 | 5 | 2022 |
| Morphology of tumor and nontumor tissue in liver resection specimens for hepatocellular carcinoma following nivolumab therapy CC Simoes, SN Thung, MI Fiel, MW Sung, ME Schwartz, SC Ward Modern Pathology 34 (4), 823-833, 2021 | 5 | 2021 |
| Budd-Chiari syndrome: a rare and life-threatening complication of Crohn’s disease CC Simoes, YA Ghouri, SN Merwat, HL Stevenson Case Reports 2018, bcr-2017-222946, 2018 | 5 | 2018 |
| Keratin 19 and mesenchymal markers for evaluation of epithelial–mesenchymal transition and stem cell niche components in primary biliary cholangitis by sequential elution … JD Paulsen, B Zeck, K Sun, C Simoes, ND Theise, L Chiriboga Journal of histotechnology 43 (4), 163-173, 2020 | 4 | 2020 |
| In vivo Safety and Immunoactivity of Oncolytic Jurona Virus in Hepatocellular Carcinoma: A Comprehensive Proteogenomic Analysis Y Zhang, M Tesfay, KU Ferdous, M Taylor, M Gabere, CC Simoes, ... bioRxiv, 2022.09. 09.507330, 2022 | 1 | 2022 |
| Oncolytic Jurona-driven systemic and intratumoral immunotherapy combined with immune checkpoint blockade boost immune response and survival in hepatocellular carcinoma models MZ Tesfay, KU Ferdous, A Cios, RS Shelton, CC Simoes, SR Post, ... Cancer Research 84 (6_Supplement), 5004-5004, 2024 | | 2024 |
| Preclinical evaluation of novel chimeric vesiculovirus mediated expression of proteolytic enzymes targeting two major stromal components of pancreatic ductal adenocarcinoma KU Ferdous, MZ Tesfay, CC Simoes, A Cios, BM Nagalo Cancer Research 84 (6_Supplement), 588-588, 2024 | | 2024 |
| Morphology of Tumor and Nontumor Tissue in Resection Specimens for Hepatocellular Carcinoma Following Nivolumab Therapy-A Single Institution Experience C Simoes, S Thung, MI Fiel, S Ward, M Schwartz LABORATORY INVESTIGATION 100 (SUPPL 1), 1552-1553, 2020 | | 2020 |
| Effects of Direct-Acting Antiviral (DAA) Therapy on Hepatic Macrophage and Lymphocyte Populations in Patients with Chronic HCV Infection OA Saldarriaga, B Dye, J Pham, A Booth, C Simoes, N Utay, ... LABORATORY INVESTIGATION 99, 2019 | | 2019 |
| Direct-Acting Antiviral Treatment in Patients with Viral Hepatitis C Results in Normalization of Serologic Markers of Autoimmune Hepatitis CC Simoes, O Saldarriaga, N Utay, MK Yi, M Ferguson, H Stevenson LABORATORY INVESTIGATION 98, 649-649, 2018 | | 2018 |
| Keratin 19 and mesenchymal markers for evaluation of epithelial-mesenchymal transition and stem cell niche components in primary biliary cholangitis by sequential elution … K Sun, C Simoes | | |
